Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9334530 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6809122 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9334523 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28262759 | 0.96 | — | — | |
| SCHEMBL5197640 | 0.96 | — | — | |
| SCHEMBL247953 | 0.96 | — | — | |
| SCHEMBL131259 | 0.96 | — | — | |
| SCHEMBL29248308 | 0.92 | — | — | |
| Iodide SCHEMBL28838222 | 0.92 | — | — | |
| Trimethylammonium SCHEMBL27979197 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12553107-B2 | Method for catalyst recovery from catalyst-coated membranes | UOP LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20250316736-A1 | POLYELECTROLYTE MULTILAYER COATED PROTON EXCHANGE MEMBRANE FOR ELECTROLYSIS AND FUEL CELL APPLICATIONS | UOP LLC | 2025-10-09 | — | — | US | claimed |
| US-12381245-B2 | Polyelectrolyte multilayer coated proton exchange membrane for electrolysis and fuel cell applications | UOP LLC (US) | 2025-08-05 | — | — | US | claimed |
| US-20250059620-A1 | METHOD FOR CATALYST RECOVERY FROM CATALYST-COATED MEMBRANES | UOP LLC | 2025-02-20 | — | — | US | claimed |
| CN-118202497-A | Polyelectrolyte multilayer films for redox flow battery applications | 环球油品有限责任公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118176326-A | Polyelectrolyte multilayer coated proton exchange membranes for electrolysis and fuel cell applications | 环球油品有限责任公司 | 2024-06-11 | — | — | CN | claimed |
| WO-2023069860-A1 | POLYELECTROLYTE MULTILAYER COATED PROTON EXCHANGE MEMBRANE FOR ELECTROLYSIS AND FUEL CELL APPLICATIONS | UOP LLC (US) | 2023-04-27 | — | — | WO | claimed |
| US-20230123137-A1 | POLYELECTROLYTE MULTILAYER COATED PROTON EXCHANGE MEMBRANE FOR ELECTROLYSIS AND FUEL CELL APPLICATIONS | UOP LLC | 2023-04-20 | — | — | US | claimed |
| US-20230124791-A1 | POLYELECTROLYTE MULTILAYER MEMBRANE FOR REDOX FLOW BATTERY APPLICATIONS | UOP LLC | 2023-04-20 | — | — | US | claimed |
| EP-0196587-B1 | METHOD FOR IMPROVING COLOR FASTNESS | NITTO BOSEKI CO., LTD. (JP) | 1989-11-08 | — | — | EP | claimed |
| US-4678474-A | WASHFASTNESS | NITTO BOSEKI CO., LTD (JP) | 1987-07-07 | — | — | US | claimed |
| EP-0196587-A2 | Method for improving color fastness | NITTO BOSEKI CO., LTD. (JP) | 1986-10-08 | — | — | EP | claimed |
| EP-4735655-A1 | METHOD FOR CATALYST RECOVERY FROM CATALYST-COATED MEMBRANES | UOP LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12553107-B2 | Method for catalyst recovery from catalyst-coated membranes | UOP LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12496282-B2 | Hepatitis B antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250316736-A1 | POLYELECTROLYTE MULTILAYER COATED PROTON EXCHANGE MEMBRANE FOR ELECTROLYSIS AND FUEL CELL APPLICATIONS | UOP LLC | 2025-10-09 | — | — | US | disclosed |
| WO-1999055725-A1 | FUNCTIONALIZED ALKYL AND ALKENYL SIDE CHAIN DERIVATIVES OF GLYCINAMIDES AS FARNESYL TRANSFERASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| EP-0899263-A2 | Fused pyrimidine derivatives and medicaments thereof for a blood oxygen partial pressure amelioration | Fujirebio Inc. (JP) | 1999-03-03 | — | — | EP | disclosed |
| EP-0196588-A2 | Process for the preparation of copolymers of N-substituted secondary monoallylamines or salts thereof | NITTO BOSEKI CO., LTD. (JP) | 1986-10-08 | — | — | EP | disclosed |
| US-4203909-A | ANTIULCER | BRISTOL-MYERS COMPANY (US) | 1980-05-20 | — | — | US | disclosed |